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Development of b-lactam resistance, production of alginate and modulation of virulence factor
expression that alters host immune responses are the hallmarks of chronic Pseudomonas
aeruginosa infection in cystic fibrosis patients. In this study, we propose that a co-regulatory
network exists between these mechanisms. We compared the promoter activities of ampR, algT/
U, lasR, lasI, rhlR, rhlI and lasA genes, representing the b-lactam antibiotic resistance master
regulatory gene, the alginate switch operon, the las and rhl quorum-sensing (QS) genes, and the
LasA staphylolytic protease, respectively. Four isogenic P. aeruginosa strains, the prototypic Alg
”
PAO1, Alg
” PAOampR, the mucoid Alg
+ PAOmucA22 (Alg
+ PDO300) and Alg
+
PAOmucA22ampR (Alg
+ PDOampR) were used. We found that in the presence of AmpR
regulator and b-lactam antibiotic, the extracytoplasmic function sigma factor AlgT/U positively
regulated PampR, whereas AmpR negatively regulated PalgT/U. On the basis of this finding we
suggest the presence of a negative feedback loop to limit algT/U expression. In addition, the
functional AlgT/U caused a significant decrease in the expression of QS genes, whereas loss of
ampR only resulted in increased PlasI and PlasR transcription. The upregulation of the las QS
system is likely to be responsible for the increased lasA promoter and the LasA protease activities
in Alg
” PAOampR and Alg
+ PDOampR. The enhanced expression of virulence factors in the
ampR strains correlated with a higher rate of Caenorhabditis elegans paralysis. Hence, this study
shows that the loss of ampR results in increased virulence, and is indicative of the existence of a
co-regulatory network between b-lactam resistance, alginate production, QS and virulence factor
production, with AmpR playing a central role.
INTRODUCTION
Pseudomonas aeruginosa, a ubiquitous, versatile saprophytic
bacterium, is a major aetiological agent of nosocomial
infections and the leading cause of mortality among patients
with cystic fibrosis (CF) (Greenberg, 2000; Rahme et al.,
1995). This Gram-negative bacillus is equipped with an
impressive arsenal of virulence factors to resist host defence
mechanisms, counteract antibacterial agents, circumvent
nutrient deprivation and withstand harsh environmental
changes (Govan & Harris, 1986; Lyczak et al., 2002;
Pedersen, 1992). One distinctive feature of P. aeruginosa
lung isolates of patients with advanced CF is that a higher
proportion of them are mucoid as compared to those from
othersitesofinfection(Doggett,1969;Ficketal.,1992).This
mucoid phenotype is the result of an overproduction of the
exopolysaccharide alginate (Evans & Linker, 1973). The
activation of genes for alginate overproduction occurs
primarily through the deregulation of algT/U or its product,
s
22, a member of the extracytoplasmic function (ECF) sigma
factors (DeVries & Ohman, 1994; Hershberger et al., 1995;
Martin et al., 1993). Genomic, proteomic and microarray
analyses have shown that AlgT/U regulates a diverse group
of genes, ranging from extracellular proteases, periplasmic
proteins like DsbA and intracellular enzymes (Firoved et al.,
2002; Firoved & Deretic, 2003; Malhotra et al., 2000).
Mucoid P. aeruginosa isolates from CF patients frequently
have a defective mucA allele, a gene downstream of algT/U
(Martin et al., 1993). The mucA gene product is an anti-
sigma factor that negatively regulates the activity of AlgT/U
(Hughes & Mathee, 1998).
Abbreviations: CF, cystic fibrosis; ECF, extracytoplasmic function; qPCR,
quantitative real-time PCR; QS, quorum sensing.
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antibiotics. One of the factors contributing to the resistance
is the existence of enzymes that can deactivate b-lactams,
known as b-lactamases (Kong et al., 2010; Rolinson, 1998).
Two inducible chromosome-encoded b-lactamases, AmpC
and PoxB (Oxa-50), have been identified in P. aeruginosa
(Girlich et al., 2004; Kong et al., 2005a; Lodge et al., 1990).
Expression of the ampC and poxB genes is tightly
controlled by AmpR, a global LysR-like transcriptional
regulator (Kong et al., 2005b). In addition, inactivation of
ampR in the prototypic non-mucoid PAO1 (henceforth
referred to as Alg
2 PAO1) resulted in high constitutive
production of b-lactamases and pyocyanin, increased LasA
staphylolytic protease activity and decreased LasB elastase
activity (Kong et al., 2005b).
The production of virulence factors in P. aeruginosa is
under the control of quorum-sensing (QS) systems
mediated by diffusible chemical signalling molecules such
as acylhomoserine lactones and quinolones. P. aeruginosa
has three QS systems – las, rhl and Pseudomonas quinolone
system that controls many virulence mechanisms (Ng &
Bassler, 2009). Transcriptome studies have led to the
identification of a large number of virulence factors that
are under QS regulation in P. aeruginosa, these include
proteases and toxins (Hentzer et al., 2003; Schuster &
Greenberg, 2006; Wagner et al., 2004).
It has long been established that the production of proteases
is inversely correlated with alginate production (Mathee
et al., 1999; Mohr et al., 1990; Ohman & Chakrabarty, 1982).
Previous comparison of Alg
2 PAO1 and its isogenic ampR
mutant strain, Alg
2 PAOampR, showed differential regu-
lation of virulence factors, including the las QS system
(Kong et al., 2005b). In the present study, we sought to
understand the regulatory network between alginate pro-
duction, protease activity, b-lactam resistance and QS in P.
aeruginosa. We hypothesized that AmpR may be differenti-
ally regulated in alginate-producing strains with consequent
effects on the protease activities. To address this, ampR was
inactivated in an alginate constitutive producer, Alg
+
PDO300, generating an Alg
+ PDOampR mutant strain.
This mutant produced exceedingly high levels of b-
lactamase, extracellular proteases and pyocyanin suggesting
that AmpR either directly or indirectly suppresses the
expression of many other virulence factors.
METHODS
Bacterial strains, plasmids and media. Table 1 shows the bacterial
strains, plasmids and primers used in this study. The bacterial strains
of Escherichia coli and P. aeruginosa were routinely cultured in Luria–
Bertani medium. Pseudomonas isolation agar (Difco) was used in
triparental mating experiments for the selection of P. aeruginosa.
Antibiotics, when used, were at the following concentrations unless
indicated otherwise: ampicillin at 50 mgm l
21, tetracycline at
20 mgm l
21, gentamicin at 30 mgm l
21 for E. coli; and carbenicillin
at 300 mgm l
21, gentamicin at 300 mgm l
21, tetracycline at
60 mgm l
21 for P. aeruginosa. For induction, 500 mg benzyl-penicillin
ml
21 was used.
DNA manipulations. All molecular techniques were performed
according to standard protocols (Ausubel et al., 1999).
Insertional inactivation of the ampR gene. Inactivation of ampR
in Alg
+ PDO300 (PAOmucA22) was performed as previously reported
using the same constructs (Kong et al., 2005b). The ampR::aacCI
fragment subcloned into pEX100T (Schweizer & Hoang, 1995) was
introduced by conjugation into an alginate-overproducing P. aerugi-
nosa, Alg
+ PDO300 (Mathee et al., 1999), with a helper strain
harbouring pRK2013 (Figurski & Helinski, 1979). The merodiploids
resulting from homologous recombination were selected with
Pseudomonas isolation agar containing gentamicin. The colonies were
then screened for gentamicin resistance and carbenicillin sensitivity by
replica plating. The insertion was confirmed by PCR and restriction
analysis of the PCR product. The Alg
+ PDO300 isogenic strain with
defective ampR (PAOmucA22ampR) is named Alg
+ PDOampR (Table
1). Complementation studies were performed using plasmid pSJ06 that
contains a PCR-amplified ampR on a low-copy-number, highly stable
shuttle vector pME6030 to minimize the effects of gene dosage (Kong
et al., 2005b). This plasmid is referred to as pAmpR.
Construction of promoter-lacZ fusions. A 330 bp ampC–ampR
intergenic region with the putative promoters was subcloned into the
promoterless lacZ in the mini-CTX-lacZ reporter plasmid (Becher &
Schweizer, 2000), creating pSJ10 (PampC-lacZ) and pSJ11 (PampR-lacZ)
(Table 1) (Kong et al., 2005b). The resulting clones were mobilized
into Alg
+ PDO300 and Alg
+ PDOampR (Table 1).
Quantitative real-time PCR (qPCR). RNA extraction was per-
formed with an RNeasy mini kit (Qiagen) following the manufac-
turer’s protocols after treatment of cells with subMIC levels (200 mg
ml
21) of penicillin G at OD600 0.6 for 1 h. The samples were
stabilized with 5% phenol/95% ethanol mixture (pH 4.7) immedi-
ately after harvesting and during cell lysis (Brencic et al., 2009). After
determining RNA quantity spectrophotometrically (Beckman DU640;
Beckman Coulter) and quality by denaturing agarose gel electro-
phoresis (Northern Max Gly; Ambion), cDNA was synthesized by
annealing NS5 random primers to total purified RNA. Subsequent
extension was carried out using SuperScript III reverse transcriptase
(Invitrogen) (Brencic et al., 2009). The cDNA was quantified and
10 ng cDNA was used per qPCR. We used the ABI 7500 cycler
(Applied Biosystems) and Power SYBR Green PCR mastermix with
ROX (Applied Biosystems) to test for expression of the ampR gene in
these strains. The ATP-binding subunit clpX (PA1802) of the ATP-
dependent protease was used as the internal control. Assays were
performed in triplicate. Primer specificity was determined from
dissociation profiles using melt curves. The cycling conditions for the
qPCR were: 95 uC for 2 min (holding); 40 cycles of 95 uC for 15 s,
60 uC for 1 min (cycling); 95 uC for 15 s, 60 uC for 1 min (melt curve
conditions).
Quantification of pyocyanin and LasA protease. Extracellular
pyocyanin was quantified as previously described (Kong et al., 2005b).
LasA protease activity was measured by determining the ability of P.
aeruginosa culture supernatants to lyse boiled Staphylococcus aureus,
as described by Kessler et al. (1993).
b-Lactamase assay. The assay of the P. aeruginosa chromosomal b-
lactamase was performed as previously described using nitrocefin as
the colorimetric substrate (Kong et al., 2005b).
b-Galactosidase assay. Assays for b-galactosidase in P. aeruginosa
were performed as previously described (Mathee et al., 1997) and
adapted into a high-throughput 96-well array (Griffith & Wolf, 2002).
P. aeruginosa–Caenorhabditis elegans paralysis assays. The
P. aeruginosa–C. elegans standard paralysis assay was modified from
D. Balasubramanian and others
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overnight. A 1:1000 dilution was plated onto brain heart infusion agar
plates. These plates were incubated for 18–24 h for the formation of
bacterial lawns. Meanwhile, a synchronized culture of L4 stage larvae
hermaphrodite Bristol N2 C. elegans was washed off an E. coli OP50-
seeded nematode growth medium plate (1.7% agar, 0.35% peptone,
Table 1. Bacterial strains, plasmids and primers used in this study
Strain/plasmid Genotype Reference
E. coli
DH5a F
2 w80dlacZDM15 D(lacZYA–argF) U169 deoR recA1 endA1 hsdR17(rk
2, mk
+)
phoA supE44 l- thi-1 gyrA96 relA1
New England Biolabs
TOP10F9 F9[lacI
q, Tn10(Tet
R)] mcrA D(mrr-hsdRMS-mcrBC) w80dlacZDM15 DlacX74 deoR
recA1 araD139 D(ara-leu)7697 galU galK rpsL (Str
R) endA1 nupG
Invitrogen
P. aeruginosa
PAO1 Prototype; Alg
2 Holloway & Morgan (1986)
PDO300 PAOmucA22; Alg
+ Mathee et al. (1999)
PKM805 PAOmucA22algT24-1; Alg
2 PDOalgT; PDO300 derivative;
Ramos et al. (2003)
PKM300 PAOampR::aacCI; Alg
2 PAOampR; Kong et al. (2005b)
PKM307 PAOmucA22 ampR::aacCI; Alg
+ PDOampR; this study
PKM308 PAOmucA22 attB::P ampC–lacZ;T c
R, Alg
+ PDO300 derivative; this study
PKM309 PAOmucA22 attB::P ampR–lacZ;T c
R, Alg
+ PDO300 derivative; this study
PKM310 PAOmucA22 ampR::aacCI attB::P ampC-lacZ;G m
R,T c
R, Alg
+ PDOampR derivative; this study
PKM311 PAOmucA22 ampR::aacCI attB::P ampR–lacZ;G m
R,T c
R, Alg
+ PDOampR derivative; this study
Plasmids
Mini-CTX-lacZ Tc
R; integration-proficient vector for single-copy chromosomal lacZ fusion Becher & Schweizer (2000)
pEX100T Ap
R; sacB oriT Schweizer & Hoang (1995)
pGEMEX-1 Ap
R; ColE1ori lacZa Promega
pKMG37 Ap
R; pQF50 containing PalgT-lacZ transcriptional fusion Mathee et al. (1997)
pLP170 Ap
R; lacZ transcriptional fusion vector that contains an RNase III splice sequence
positioned between the MCS and lacZ
Preston et al. (1997)
pLPLA Ap
R; pLP170 containing PlasA-lacZ transcriptional fusion Preston et al. (1997)
pLPLB Ap
R; pLP170 containing PlasB-lacZ transcriptional fusion Preston et al. (1997)
pLPR1 Ap
R; pLP170 containing PrhlI-lacZ transcriptional fusion Van Delden & Iglewski (1998)
pME6030 Tc
R; oriVpVS1 oriVp15A oriT Heeb et al. (2000)
pPCS223 Ap
R; pLP170 containing PlasI-lacZ transcriptional fusion Van Delden & Iglewski (1998)
pPCS1001 Ap
R; pLP170 containing PlasR-lacZ transcriptional fusion Pesci et al. (1997)
pPCS1002 Ap
R; pLP170 containing PrhlR-lacZ transcriptional fusion Pesci et al. (1997)
pQF50 Ap
R; broad-host-range vector with promoterless lacZ Farinha & Kropinski (1990)
pRK2013 Km
R; ColE1ori-Tra (RK2)
+ Figurski & Helinski (1979)
pSJ01 Ap
R; pGEMEX-1 with a 1220 bp EcoRI–BamHI flanked fragment containing ampR Kong et al. (2005b)
pSJ06 Ap
R; pME6030 with a 1220 bp EcoRI–BamHI flanked fragment containing ampR
(referred to as pAmpR)
Kong et al. (2005b)
pSJ07 Ap
R; pEX100T derivative with ampR::aacCI Kong et al. (2005b)
pSJ09 Ap
R,G m
R; pGEMEX-1 with a 330 bp EcoRI–BamHI flanked fragment containing
ampC-ampR intergenic region
Kong et al. (2005b)
pSJ10 Tc
R; CTX-lacZ fused with ampC promoter, PampC Kong et al. (2005b)
pSJ11 Tc
R; CTX-lacZ fused with ampR promoter, PampR Kong et al. (2005b)
pUCGm Ap
R,G m
R; pUC19 derivative containing gentamicin cassette Schweizer (1993)
Primers
SBJ01ampRFor* 59-GGAATTCTGGCGAACAGCAGTGTGGAAGCGG-39
SBJ02ampRRev* 59-CGGGATCCATTCCAATCACAACCCCAACGCC-39
SBJ03ampCRFor* 59-GGAATTCTGAGGCCGCGCGGCAGACGCTTGAACA-39
SBJ04ampCRRev* 59-CGGGATCCCATGAGGATTGGCGTCCTTTG-39
DBS_QRTAmpRF 59-CATTGGCCTTCATCACCGGTTGTA-39
DBS_QRTAmpRR 59-GGTTTCTCATGCAGCCCACGACAA-39
*The italicized portion of the sequence indicates a restriction site in a PCR product prepared with the primer.
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cholesterol). The worms were centrifuged at 1300 g for 2 min and
washed twice with M9 medium to remove residual E. coli bacteria. A
total of 30 to 50 worms was then added to the P. aeruginosa bacterial
lawns. Both live and paralysed worms were scored at 1, 2 and 4 h by
microscopic observation. The analysis was performed in triplicate.
Statistical analysis. All data were analysed with one-way ANOVA
using the statistical software package SPSS (SPSS).
RESULTS
PampC expression in ampR mutants
We have previously reported that in the non-mucoid
strain, AmpR positively regulates ampC expression but
negatively controls the expression of poxB (Kong et al.,
2005a, b). To test whether such opposing controls remain
true in the Alg
+ background, strains were constructed with
a single copy of the ampC promoter fused to a
promoterless reporter gene, lacZ (PampC-lacZ). This was
integrated into the Alg
+ PDO300 and the Alg
+ PDOampR
chromosomes via attB-attP site-specific recombination,
thus allowing mimicking of the chromosomal regulation.
In the absence of inducer, the PampC-lacZ activity remained
at a basal level in Alg
+ PDO300 and Alg
+ PDOampR
strains (Table 2). A significant ninefold induction of the
ampC promoter was observed in Alg
+ PDO300 upon
challenge with b-lactams (Table 2). However, the induci-
bility of the PampC was lost in Alg
+ PDOampR.
Based on the above analysis, we expected to observe a loss
of b-lactamase activity concomitant with the loss of ampR.
However, the Alg
+ PDOampR expressed a statistically
significant sixfold higher b-lactamase compared to the
parent Alg
+ PDO300 in the absence of antibiotics (Fig. 1).
No further induction was demonstrated in the presence of
the inducer. This phenotype varied from the parental strain
Alg
+ PDO300, which showed only a threefold inducible
phenotype (Fig. 1). The inducible phenotype was restored
in Alg
+ PDOampR mutant by complementation with
pAmpR. The high b-lactamase activity in an ampR mutant
has been shown previously to be due to the uninhibited
expression of an oxacillinase poxB gene, rather than the
elevated expression of ampC gene (Kong et al., 2005b).
ampR transcription in alginate-overproducing
strains
The LysR family of transcriptional regulators is known to
repress their own transcription as in the case of Citrobacter
freundii AmpR (Lindquist et al., 1989). However, we have
previously reported that P. aeruginosa AmpR does not
autoregulate in the prototypic strain Alg
2 PAO1 (Kong
et al., 2005b). To determine if there is a change in the
AmpR autoregulation in Alg
+ strains, a single-copy fusion
of PampR-lacZ was introduced at the attP site in Alg
+
PDO300 and Alg
+ PDOampR. In the absence of inducers,
the ampR transcription remained at low levels in both
strains (Table 2). In the presence of inducers, a significant
increase in PampR expression was seen in Alg
+ PDO300
(Table 2). Comparing the genotypes of the isogenic Alg
2
PAO1 and Alg
+ PDO300 strains, this significant increase
was likely due to the uninhibited activity of the ECF sigma
factor AlgT/U in the latter. This suggests that AlgT/U
activates the ampR promoter in the presence of inducers.
Due to loss of ampR, no significant induction of PampR was
seen in Alg
+ PDOampR. In order to test AlgT/U regulation
of ampR, mRNA levels of ampR were determined by qPCR
with the Alg
2 PAO1, Alg
+ PDO300 and Alg
2 PDOalgT
strains. The Alg
+ PDO300 strain showed an increase in the
ampR mRNA levels (relative quantity of 2.1±0.2 com-
pared to 1.0±0 in Alg
2 PAO1) indicating positive
regulation of ampR by AlgT/U. Mutation in algT/U in
Alg
2 PDOalgT led to a decrease in this expression (relative
quantity 1.4±0.1 compared to 2.1±0.2 in Alg
+ PDO300)
supporting our hypothesis of positive regulation of ampR
by AlgT/U and concurs with the transcriptional fusion
assays. These results suggest that both AlgT/U and AmpR
Table 2. b-Galactosidase activities of ampC and ampR promoters
Strain PampC-lacZ (Miller units) P value* PampR-lacZ (Miller units) P value*
Non-induced Induced Non-induced Induced
Alg
2 PAO1D 124.1±11.6 1644.2 ± 33.7 ,0.05 77.1±8.7 123±1.2 NS
Alg
2 PAOampRD 113.2±7.5 122.3±7.4 NS 96.3±15.2 106.0±16.0 NS
P valued NS ,0.05 NS NS
Alg
+ PDO300 104.2±4.5 957.5±161.4 ,0.05 79.5±26.3 332.8±14.3 ,0.05
Alg
+ PDOampR 142.4±4.9 143.8±6.9 NS 155.8±0.8 153.0±2.1 NS
P value§ NS ,0.05 NS ,0.05
NS, Not significant (P values .0.05).
*ANOVA compares the activity values between the presence (+) and absence (2) of inducers.
DThese data are presented in a previous paper (Kong et al., 2005b); they are included here for comparison.
dANOVA compares the activity values between the Alg
2 PAO1 and the mutant Alg
2 PAOampR.
§ANOVA compares the activity values between the Alg
+ PDO300 and the mutant Alg
+ PDOampR.
D. Balasubramanian and others
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presence of inducers.
ampR mutation affects algT/U transcription
The loss of inducibility of ampR transcription in the Alg
+
PDOampR background provided us with the first clue of
the existence of a co-regulatory network involving b-lactam
resistance and alginate production. To determine if this
relationship is bidirectional, a PalgT/U-lacZ fusion construct
was introduced into Alg
2 PAO1, Alg
+ PDO300 and the
corresponding ampR mutant strains. As expected, the
expression of algT/U promoter is constitutive in Alg
2
PAO1 and increased in Alg
+ PDO300 (Fig. 2). Insertional
inactivation of ampR in Alg
2 PAO1 and Alg
+ PDO300
resulted in an approximately twofold increase in PalgT/U
activity in the absence of inducer. The effect of ampR
mutation in Alg
2 PAOampR is the same as the known
AlgT/U repressor mucA mutation (Alg
+ PDO300) with
respect to PalgT/U expression, indicating negative regulation
of PalgT/U by AmpR. The AmpR-regulation of algT/U
promoter in these strains was not significantly affected by
b-lactam antibiotic. The consistent increase in PalgT/U in
the absence of ampR suggests that AmpR is a negative
modulator of the ECF sigma factor, AlgT/U.
AlgT/U-dependent regulation of pyocyanin
Our quantitative analysis showed that the Alg
+ PDO300
produced threefold less pyocyanin than Alg
2 PAO1 in the
absence of b-lactam antibiotics (Table 3). This finding
confirms that the AlgT/U sigma factor suppresses the
production of pyocyanin. The presence of inducer resulted
in an increase in pyocyanin production, albeit at low levels
in Alg
+ PDO300. However, the Alg
+ PDOampR mutant
produced a significantly high basal level of pyocyanin,
which was inducible in the presence of b-lactam antibiotics
(Table 3). Expressing ampR in trans in Alg
+ PDOampR on
a low-copy-number plasmid restored the phenotype to the
parental strain, Alg
+ PDO300 (data not shown). On the
basis of this data we further argue that AmpR acts as a
negative regulator of pyocyanin production.
LasA protease activity and lasA promoter
expression in Alg
+ PDOampR
The inverse relationship seen between alginate production
and proteases is presumed to be AlgT/U-dependent (Mathee
et al., 1999; Mohr et al., 1990; Ohman & Chakrabarty, 1982).
Thus, a significant increase in algT/U expression in Alg
+
PDOampR (Fig. 2) should result in downregulation of LasA
protease expression. As expected, in comparison to the wild-
type Alg
2 PAO1, Alg
+ PDO300 produced 2.3-fold less LasA
protease. However, loss of ampR resulted in a marginal
increase in the LasA protease activity (Table 3) in an
inducer-independent manner. To further confirm the above
hypothesis, a PlasA-lacZ transcriptional fusion plasmid was
introduced into Alg
2 PAO1, Alg
+ PDO300 and the ampR
mutantstrains(Table3).InconcordancetotheLasA activity
analysis, the PlasA levels were low in all mucoid strains,
suggesting that the transcription of these promoters was
suppressed (Table 3). Furthermore, the PlasA-lacZ fusion
expression was increased twofold to threefold in Alg
2
Fig. 1. b-Lactamase expression in the Alg
+ PDOampR mutant.
Assays were performed using the parent strain Alg
+ PDO300, the
mutant Alg
+ PDOampR and Alg
+ PDOampR (pAmpR) in the
absence (”) and presence (+) of an inducer. The plasmid pAmpR
carries the wild-type ampR gene on a broad-host-range low-copy-
number plasmid pME6030 (Heeb et al., 2000). Fresh cultures of
OD600 0.6–0.8 were induced with 100 mg benzylpenicillin ml
”1 for
3 h before harvesting. Assays were performed on sonicated lysate
using nitrocefin as a chromogenic substrate. Assays were
performed in triplicate. One Miller unit of b-lactamase is defined
as 1 nmol nitrocefin hydrolysed min
”1 (mg protein)
”1.
Fig. 2. The effects of the ampR mutation on algT/U transcription.
The promoter fusion PalgT/U-lacZ was introduced into Alg
” PAO1,
Alg
” PAOampR, Alg
+ PDO300 and Alg
+ PDOampR. Induction
was carried out using 500 mg benzylpenicillin ml
”1 and the b-
galactosidase activity was determined in Miller units after 30 min
incubation. The basal level of expression was detected in the
promoterless lacZ vector, pLP170.
Transcriptional co-regulation in P. aeruginosa
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+ PDOampR, as compared to their
respective parental strains (Table 3). These results suggest
that AmpR is a negative regulator of lasA expression.
QS gene expression in mucoid ampR mutants
In line with previous observations (Kong et al., 2005b), we
postulated that the slight increase of lasA expression in Alg
+
PDOampR could be due to upregulation of the las system.
To address this, all the four QS promoter fusions, PlasI-lacZ,
PlasR-lacZ,P rhlI-lacZ and PrhlR-lacZ were introduced into
Alg
2 PAO1, Alg
2 PAOampR, Alg
+ PDO300 and Alg
+
PDOampR. As we postulated, the Alg
+ PDO300 exhibited
significantly lower QS gene expression as compared to Alg
2
PAO1. There was no difference in the PlasR expression in
Alg
+ PDO300 and Alg
+ PDOampR (Fig. 3). However, the
PlasI activity was significantly increased in Alg
+ PDOampR.
Similar to the Alg
2 PAOampR, the loss of ampR in Alg
+
PDO300 resulted in minimal alteration of PrhlI and PrhlR
expression. Thus, AmpR negatively regulates lasI expression
in alginate-overproducing strains.
Role of AmpR in virulence
The nematode C. elegans has been used as a bacterial
pathogenesis model for the determination of virulence in P.
aeruginosa (Gallagher & Manoil, 2001; Sifri et al., 2005; Tan
et al., 1999). This simple host–pathogen interaction model
was used to ascertain the virulence of Alg
2 PAO1, Alg
2
PAOampR, Alg
+ PDO300 and Alg
+ PDOampR.A s
expected, there was no observable paralysis in the negative
control (E. coli OP50) plates (Fig. 4) and during the first
hour of incubation with all the four isogenic P. aeruginosa
strains. Consistent with the molecular and biochemical
data, Alg
2 PAOampR paralysed C. elegans at a significantly
(P,0.05) faster rate than the wild-type Alg
2 PAO1 (Fig. 4).
The lowest survival was seen at the second hour, 19% with
Alg
2 PAOampR, as compared to 34% with Alg
2 PAO1
(Fig. 4). In addition, Alg
+ PDOampR also showed a higher
virulence than Alg
+ PDO300 with 85 and 98% survival at
4 h post-incubation, respectively (Fig. 4). The increase in
virulence in Alg
2 PAOampR and Alg
+ PDOampR could be
restored using pAmpR (Fig. 4), suggesting that AmpR acts
as a negative regulator of P. aeruginosa virulence.
DISCUSSION
AmpR is the master transcriptional regulator involved in
b-lactam antibiotic resistance. We have demonstrated
Fig. 3. The effects of the ampR mutation on QS las and rhl gene
transcription. The alteration in the transcription of the QS systems
in Alg
” PAO1 (hatched bars), Alg
” PAOampR (grey bars), Alg
+
PDO300 (white bars) and Alg
+ PDOampR (black bars) was
monitored using four transcriptional fusions, PlasI-lacZ,P lasR-lacZ,
PrhlI-lacZ and PrhlR-lacZ. The promoterless lacZ vector has a low
basal level of activity of ,20 Miller units.
Table 3. Pyocyanin, LasA and PlasA-lacZ activities
Inducer* Pyocyanin [mg( mg total protein)
”1]D LasA [DOD600 h
”1 (mg protein)
”1]d PlasA-lacZ (Miller
units)§
” + ” + ”
Alg
2 PAO1|| 0.285±0.219 2.293±0.216 0.310±0.065 0.317±0.059 790.0±128.9
Alg
2 PAOampR|| 2.934±0.761# 3.317±0.638 1.109±0.099# 0.951±0.045# 1970.5±312.6#
Alg
+ PDO300 0.102±0.017** 0.324±0.051 0.135±0.011 0.147±0.024 246.5±26.5
Alg
+ PDOampR 0.538±0.026DD 2.518±0.640DD 0.268±0.017 0.143±0.025 536.0±19.0
*Induction was carried out using 500 mg benzylpenicillin ml
21 for P. aeruginosa.
DPyocyanin concentrations were expressed as mg pyocyanin produced (mg total protein)
21.
dLasA activities were determined as the reduction of OD600 over a period of 1 h (mg total protein)
21.
§b-Galactosidase assays were performed in a high-throughput 96-well array and the results expressed in Miller units.
||These data are presented in a previous paper (Kong et al., 2005b); they are included here for comparison.
P,0.05 between non-induced and induced in the same strain.
#P,0.05 between Alg
2 PAO1 and Alg
2 PAOampR under the same conditions.
**P,0.05 between Alg
2 PAO1 and Alg
+ PDO300 under the same conditions.
DDP,0.05 between Alg
+ PDO300 and Alg
+ PDOampR under the same conditions.
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b-lactamases, P. aeruginosa AmpR plays a role in
controlling the expression of some virulence factors
(Kong et al., 2005b). In this study, we have shown that
there is a complex regulatory network between b-lactam
resistance, alginate production, and QS and virulence gene
expression, factors determining the establishment of both
acute and chronic P. aeruginosa infection.
ampR autoregulation requires AlgT/U
Previous studies in Enterobacteriaceae spp. have demon-
strated that the transcription of ampR is autoregulatory
(Lindquist et al., 1989); but, we reported otherwise for the
non-mucoid strain of P. aeruginosa (Kong et al., 2005b).
Data presented here show that the autoregulatory mech-
anism of ampR could be seen in the presence of inducers in
an alginate overproducing strain, Alg
+ PDO300, but was
lost in the absence of ampR (Table 2). This suggests that the
regulation of ampR transcription requires AlgT/U, and is
AmpR-dependent in Alg
+ PDO300. The requirement of
these factors for autoregulation explains the inconsistency
seen with the Enterobacteriaceae models: in an in vivo system
using the heterologous host E. coli, the PampR-lacZ activity
was repressed threefold in the presence of Citrobacter
freundii AmpR (Lindquist et al., 1989). However, this mode
of regulation was lost in a minicell system with Enterobacter
cloacae AmpR (Lindberg & Normark, 1987).
The intriguing autoregulatory mechanism seen in the
alginate-overproducing PAO1 derivative may have import-
ant clinical implications: the data with Alg
2 PAO1 suggest
that thisearly colonizeris ableto induce the production of b-
lactamases upon b-lactam chemotherapy. However, this
non-mucoid strain is unable to autoregulate ampR,i n d i c -
ating that the production of b-lactamases is induced only
upon contact with b-lactam antibiotics. This phenomenon
may be disadvantageous during antibiotic selections.
Persistence of the organism in the lungs of patients with
CF will ultimately result in the selection of mucoid strains
that hyperproduce alginate (Høiby, 1975). This phenotypic
alteration is accompanied by resistance to antibiotics and
immune clearance (Giwercmanet al.,1 9 9 1 ) .D a t af r o mA l g
+
PDO300 suggest that the selected mucoid P. aeruginosa
strains are primed to b-lactam resistance by the increased
production of AmpR, and hence b-lactamases, upon contact
with b-lactam antibiotics. This observation should be further
verified using clinical strains with commonly used b-lactams.
AmpR is a negative regulator of algT/U
The simultaneous presence of b-lactam resistance and
alginate-overproduction suggests a possible co-regulation
of these phenomena. We have shown here that autoregula-
tion of ampR is AlgT/U-dependent. Loss of the ampR gene in
Alg
2 PAO1 resulted in a significant increase in the promoter
activity of algT/U operon (Fig. 2). However, this did not
phenotypically alter Alg
2 PAO1 to an Alg
+ phenotype due
to the post-transcriptional control of AlgT/U by the anti-
sigma factor, MucA, expressed downstream of algT/U
(Hughes & Mathee, 1998). In Alg
+ PDO300, like in Alg
2
PAO1, there is an increase of algT/U expression upon loss of
ampR. Data from these two strain backgrounds suggest that
AmpR suppresses the expression of algT/U.
The possible mechanistic interaction between the alg and
amp regulons has been reported in Azotobacter vinelandii,
whereamutationinampDE,encodingnegativeregulatorsof
b-lactamases, resulted in elevated expression of alginate
biosynthetic genes (Nu ´n ˜ez et al., 2000). In addition,
microarray data also have demonstrated that alginate
production is induced upon antibiotic challenge (Bagge
et al., 2004), and a later study identified AlgT, AlgW and Prc
proteases as being involved in this process (Wood et al.,
2006). Our results are further supportive of their findings in
which b-lactam resistance and alginate production of P.
aeruginosa are co-regulated. This co-regulation is likely
mediated by AmpR-AlgT/U interaction. Future studies will
address this potential interaction.
AlgT/U and AmpR are regulators of virulence
factors
Multiple QS-dependent phenotypes, including LasA and
pyocyanin production, are differentially regulated in an
ampR mutant, and are probably an indirect effect of AmpR
on the QS system. We have previously shown that deletion
Fig. 4. Kinetics of the paralysis of C. elegans by P. aeruginosa
Alg
” PAO1 wild-type strain (—), Alg
” PAOampR (– ..–),
complemented Alg
” PAOampR(pAmpR) (– . –), Alg
+ PDO300
(-.-), Alg
+ PDOampR (--) and complemented Alg
+
PDOampR(pAmpR) (...). L4 stage larval hermaphrodite Bristol N2
C. elegans were placed on each brain heart infusion agar plate
containing a bacterial lawn and scored for dead worms by
microscopic examination. E. coli OP50 (— —) was used as a
negative control. Values are the mean±SD of triplicate analyses.
Results were statistically significant (P,0.05 for PAO1 vs
PAODampR at 2 h, and PDO300 and PDOampR at 4 h).
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Alg
2 strain, suggesting that lasA expression is suppressed by
AmpR (Kong et al., 2005b). We postulated that a similar
observation should be obtained in an Alg
+ strain. As
expected, the absence of ampR in the presence of functional
AlgT/U elevated the promoter expression of lasA and the
production of LasA protease (Table 3). This alteration in LasA
synthesis suggests that both AlgT/U and AmpR negatively
impact transcription of the lasA gene. Although the inverse
correlation between alginate and protease production has
been repeatedly reported, our results establish that this
correlation is mediated through the downregulation of QS in
Alg
+ strains. Comparing two isogenic strains, Alg
2 PAO1
and Alg
+ PDO300, the see-saw effect is brought upon by the
ECF sigma factor, AlgT/U. Since sigma factor, an essential
component of RNA polymerase, is unlikely to be involved in
the repression of gene expression, AlgT/U-mediated down-
regulation of QS genes is probably indirect.
To determine whether the in vitro alterations in virulence
factor expression could be translated into significant in vivo
killing, the C. elegans–P. aeruginosa interaction model was
employed. As predicted, loss of ampR strongly correlated
with an increase in virulence with both Alg
2 PAOampR and
Alg
+ PDOampR showing higher rates of C. elegans paralysis
as compared to their parent strains (Alg
2 PAO1 and Alg
+
PDO300, respectively). The significantly higher amounts of
pigmentation produced by ampR mutants compared to the
isogenic wild-type strain explains the higher killing rate,
which is in agreement with other studies (Tan et al., 1999).
Concluding remarks
The data presented here reveal a complex co-regulatory
network between b-lactam resistance, alginate production,
QS and virulence gene expression. We have previously
shown that AmpR regulates AmpC and PoxB b-lactamases
and QS-dependent proteases (Kong et al., 2005a, b). In this
paper, that observation is further extended to include the
alginate master regulator, AlgT/U. Importantly, we show
that the positive autoregulation of ampR requires AlgT/U,
whereas AmpR negatively regulates algT/U expression
(Fig. 2) serving as a negative feedback loop to limit the
AlgT/U expression. We propose that this intimate crosstalk
between these two global regulators provides a potential
molecular framework for the simultaneous occurrence of
b-lactam resistance and alginate-overproducing strains in
chronic CF lung infections. Further studies on clinical
isolates are warranted to understand the complex regula-
tory network linking all these critical factors in establishing
infections. Delineating the interplaying factors and reg-
ulatory network is of fundamental significance to under-
standing the pathogenesis of P. aeruginosa.
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